In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 23rd, 2004 | 16 | Yes |
Popular Name: Sulfathiazole Sulfathiazole
Find On: PubMed — Wikipedia — Google
CAS Numbers: 144-74-1 , 169905-10-6 , 4151-50-2 , 72-14-0 , [144-74-1] , [4151-50-2] , [72-14-0]
4-amino-N-(1,3-thiazol-2-yl)benzene-1-sulfonamide
4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide
4-Amino-N-(thiazol-2-yl)benzenesulfonamide
4-amino-N-1,3-thiazol-2-ylbenzenesulfonamide
4-Amino-N-thiazol-2-yl-benzenesulfonamide
72-14-0; C11169; Sulfathiazole
72-14-0; D01047; Sulfathiazole (USP/INN)
72-14-0; Prestwick_430; Sulfathiazole
benzenesulfonamide, 4-amino-N-2-thiazolyl-
CPD-11285; Neostrepsan; Norsulfasol; Norsulfazole; sulfathiazole
N(1)-(2-Thiazolyl)sulfanilamide
N-Ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-1-octanesulfonamide
Sodium sulfathiazole;Sulphathiazole
sodium [(4-aminophenyl)sulfonyl](1,3-thiazol-2-yl)azanide
Sulfathiazole (Triple Sulfa) (FDA); Sulfathiazole (BAN
Sulfatiazol; sulfathiazol; sulfathiazole; sulfathiazolum
USP); Sulfathiazole (Triple Sulfa) (FDA); Sulfathiazole Sodium (MI
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.76 | 1.09 | -15.04 | 3 | 5 | 0 | 88 | 255.324 | 2 | ↓ |
Mid Mid (pH 6-8) | 0.83 | 0.53 | -49.05 | 2 | 5 | -1 | 87 | 254.316 | 3 | ↓ |
Lo Low (pH 4.5-6) | 1.76 | 0.95 | -57.96 | 4 | 5 | 1 | 90 | 256.332 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 200 | TCI |
Melting_Point | 200-203? | Alfa-Aesar |
Melting_Point | 200-203° | Alfa-Aesar |
MP | 202 - 204 | Enamine Building Blocks |
MP | 202...204 | Enamine Building Blocks |
ALOGPS_SOLUBILITY | 9.21e-01 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 95% | Fluorochem |
Therapy | antibacterial | SMDC Iconix |
Target | Antifection | Selleck Chemicals |
mechanism | Dihydrofolate reductase inhibitor | IBScreen Bioactives IBScreen Bioactives |
mechanism | Dihydrofolate synthesis inhibitor | IBScreen Bioactives |
Patent Database Links | EP1537858; EP1538164; EP1717247; US2003105066; US2007203079; US2007207222; US2007243132; WO2007103687 | ChEBI |
mechanism | Folate-antagonist | IBScreen Bioactives |
Target | Others | Selleck Chemicals |
biological_use | Sulfonamide | IBScreen Bioactives IBScreen Bioactives |
biological_use | Used in treatment of severe staphylococcal infections, but use restricted due to its systemic toxicity. | IBScreen Bioactives |